EBMcalc Neurology
EBMcalc Neurology is a clinical decision support tool for neurologists, providing a library of interactive medical calculators and scoring systems on iOS.
The App DNA
What makes this app unique?
Medical professionals use the tool to standardize risk assessments and diagnostic criteria during patient consultations, replacing manual reference books with digital, interactive logic.
For Neurologists and medical professionals requiring evidence-based clinical calculators and decision support tools.
What does it look like?
Key features
Interactive calculators for scoring systems like NIH Stroke Score and CHADS2, mapped to neurology and general medicine.
NodeJS-based API providing JSON-formatted calculation results for integration into third-party apps and AI workflows.
Interactive tools for converting medical units, including opioid and corticosteroid dosing.
How much does it cost?
The flat-fee, one-time purchase model for the mobile client contrasts with the subscription-based pricing prevalent in current medical reference apps.
Velocity
Dormant developmentopaqueShow more...
EBMcalc Neurology has been inactive for 1,096 days, placing it firmly in the zombie category. The development history consists of a single version release within the observed window, indicating a complete cessation of updates. There is no evidence of ongoing maintenance, feature development, or live operations support for the platform.
Who built it?
Foundation Internet Services
8 apps tracked · Medical
User Sentiment
What do users think recently?
Recent user voice shows an upset sentiment.
How are ratings & reviews evolving?
What users say, by theme
- The application lacks sufficient clinical content regarding neurology to justify the financial cost for medical professionals
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for EBMcalc Neurology
How's the Medical market?
EBMcalc Neurology maintains a static presence in the medical category with a 1.0-star rating based on a single review. The absence of updates since 2023 signals a lack of competitive pressure in the mobile reference space.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for EBMcalc Neurology
Where is it heading?
The medical reference market is shifting toward subscription-based, cloud-integrated tools that update in real-time. EBMcalc Neurology's static, unmaintained state leaves it exposed to obsolescence, signaling a likely exit from the consumer mobile space.
- The three-year update gap indicates a lack of active maintenance, which erodes the app's utility for clinical decision support in a fast-changing field.
The SWOT
- Extensive library of 50+ clinical criteria sets provides immediate utility for standardized neurological assessments
- Licensing the EBMcalc API to EHR systems could transition the product into a B2B data-service
Next best moves
Sunset the standalone mobile app because the three-year update gap prevents competitive relevance → reallocate resources to API licensing
The counter-intuitive read
The lack of mobile updates is a strategic…
Read the full takeBottom line
The three-year development freeze renders the mobile client a liability for professional use, as static clinical tools cannot keep pace with evolving neurology guidelines. Sunset the mobile storefront to focus on the B2B API licensing model, which offers a more sustainable revenue path.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Developer website, source
- [2] App Store
Report last updated